Verapamil Hydrochloride
- Product NDC
- 59923-605
- 11-digit product format
- 599230605
- Labeler code
- 59923
- Product ID
- 59923-605_c287fcfd-948b-6448-e053-2a95a90a5b04
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Verapamil Hydrochloride
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Areva Pharmaceuticals
- Application
- ANDA213352
- Marketing category
- ANDA
- Marketing start
- 2020-01-01
- Marketing end
- 0000-00-00
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 3 mg/mL
- Pharmacologic classes
- P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59923-605-02 | Verapamil Hydrochloride | 2 mL in 1 VIAL | INJECTION | 2 | | 6 |
| 59923-605-02 | Verapamil Hydrochloride | 5 in 1 CARTON | INJECTION | 5 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59923-605 | VERAPAMIL HYDROCHLORIDE INJECTION [AREVA PHARMACEUTICALS] | 6 | Legacy NDC, 2 package rows | 20250101_88dfef42-d3fd-be1c-e053-2a95a90a0ea0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Status |
|---|
| 59923-605-02 | 59923060502 | 2 mL in 1 VIAL | 2 ml | Historical |